Your session is about to expire
← Back to Search
Cognitive Behavioral Therapy
telepsychology for Depression
N/A
Recruiting
Led By Kazuko Shem, MD
Research Sponsored by Santa Clara Valley Health & Hospital System
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 1 week
Treatment 3 months
Follow Up 3 months
Awards & highlights
No Placebo-Only Group
Summary
This trial will test whether CBT via tele-psychology is an effective treatment for persons with SCI who have recently been discharged from rehabilitation and are experiencing depressed mood.
Eligible Conditions
- Depression
- Spinal Cord Injury
Timeline
Screening ~ 1 week0 visits
Treatment ~ 3 months0 visits
Follow Up ~ 3 months0 visits
Screening ~ 1 week
Treatment ~ 3 months
Follow Up ~3 months
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Change in Patient Health Questionnaire-9
Secondary study objectives
Change in Generalized Anxiety Disorder-7
Change in Satisfaction with Life Scale
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: interventionExperimental Treatment1 Intervention
telepsychology treatment
Group II: usual careActive Control1 Intervention
standard of care
Find a Location
Who is running the clinical trial?
Santa Clara Valley Health & Hospital SystemLead Sponsor
15 Previous Clinical Trials
4,391 Total Patients Enrolled
1 Trials studying Depression
377 Patients Enrolled for Depression
University of California, San FranciscoOTHER
2,586 Previous Clinical Trials
14,899,904 Total Patients Enrolled
73 Trials studying Depression
26,463 Patients Enrolled for Depression
Kazuko Shem, MDPrincipal InvestigatorSanta Clara Valley Medical Center
2 Previous Clinical Trials
111 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You have mild to moderate depression, as measured by a questionnaire called the PHQ-9, with a score between 5 and 14.You are currently experiencing a severe mental illness called acute psychosis.You do not understand or speak English well.You have a mild to moderate level of depression based on a questionnaire score between 5-14.You are an adult who has suffered a spinal cord injury, either from a traumatic or non-traumatic cause, regardless of the location of the injury.Intact cognitive status (i.e., full scale MoCA ≥ 25)
Research Study Groups:
This trial has the following groups:- Group 1: usual care
- Group 2: intervention
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 1 Weeks to process to see if you qualify in this trial.
- Treatment: You will receive the treatment for 3 Months
- Follow Ups: You may be asked to continue sharing information regarding the trial for 3 Months after you stop receiving the treatment.
Depression Patient Testimony for trial: Trial Name: NCT03711760 — N/A
Other Trials to Consider
Popular Categories
Learn More About These Treatments
Share this study with friends
Copy Link
Messenger